Blog

Comparing lobular vs. ductal Inflammatory Breast Cancer

Photo of Yoshiko Iwai from doximity.com

Aug 12, 2024, 12:58

Comparing lobular vs. ductal Inflammatory Breast Cancer

Society of Surgical Oncology shared on X:

“A new study in Annals of Surgical Oncology, comparing lobular vs. ductal IBC, shows that lobular IBC patients are more likely to be node-negative at presentation but node-positive at surgery, often with less comprehensive nodal exams.

Society of Surgical Oncology

‘Guideline-Concordant Surgical Care for Lobular Versus Ductal Inflammatory Breast Cancer‘

Authors: Yoshiko Iwai, Stephany Perez-Rojas, Samantha M. Thomas, Audree B. Tadros, Steven G. Woodward, Jennifer Q. Zhang, Leisha C. Elmore, Gary M. Freedman, Julia C. Tchou, Aaron D. Bleznak, Oluwadamilola M. Fayanju.”

Comparing lobular vs. ductal Inflammatory Breast Cancer

Source: Society of Surgical Oncology/X

Aaron D. Bleznak Audree B. Tadros Breast Cancer cancer Gary M. Freedman Jennifer Q. Zhang Julia C. Tchou Leisha C. Elmore Oluwadamilola M. Fayanju OncoDaily Oncology Samantha M. Thomas Society of Surgical Oncology Stephany Perez-Rojas Steven G. Woodward Yoshiko Iwai

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage